SE1064009T3 - Anvaendning av extract av irisvaexter och Cimicifuga racemosa och tektorigenin saesom oestrogenartat organselektivt laekemedel utan uterotropverkan - Google Patents

Anvaendning av extract av irisvaexter och Cimicifuga racemosa och tektorigenin saesom oestrogenartat organselektivt laekemedel utan uterotropverkan

Info

Publication number
SE1064009T3
SE1064009T3 SE99913282T SE99913282T SE1064009T3 SE 1064009 T3 SE1064009 T3 SE 1064009T3 SE 99913282 T SE99913282 T SE 99913282T SE 99913282 T SE99913282 T SE 99913282T SE 1064009 T3 SE1064009 T3 SE 1064009T3
Authority
SE
Sweden
Prior art keywords
extract
tectorigenin
estrogenic
cimicifuga racemosa
iris
Prior art date
Application number
SE99913282T
Other languages
English (en)
Other versions
SE1064009T4 (sv
SE1064009T5 (sv
Inventor
Wolfgang Wuttke
Hubertus Jarry
Volker Christoffel
Barbara Spengler
Michael Popp
Original Assignee
Bionorica Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=7861630&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=SE1064009(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Bionorica Ag filed Critical Bionorica Ag
Publication of SE1064009T3 publication Critical patent/SE1064009T3/sv
Publication of SE1064009T5 publication Critical patent/SE1064009T5/sv
Publication of SE1064009T4 publication Critical patent/SE1064009T4/sv

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/71—Ranunculaceae (Buttercup family), e.g. larkspur, hepatica, hydrastis, columbine or goldenseal
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/12—Drugs for genital or sexual disorders; Contraceptives for climacteric disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/30—Oestrogens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Medical Informatics (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Botany (AREA)
  • Rheumatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Endocrinology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Reproductive Health (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Diabetes (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
SE99913282T 1998-03-19 1999-03-19 Anvaendning av extract av irisvaexter och Cimicifuga racemosa och tektorigenin saesom oestrogenartat organselektivt laekemedel utan uterotrop verkan SE1064009T4 (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19812204A DE19812204A1 (de) 1998-03-19 1998-03-19 Verwendung von Extrakten aus Cimicifuga racemosa und Belamcanda sinensis als estrogenartiges organselektives Arzneimittel ohne uterotrope Wirkung

Publications (3)

Publication Number Publication Date
SE1064009T3 true SE1064009T3 (sv) 2003-01-21
SE1064009T5 SE1064009T5 (sv) 2003-04-15
SE1064009T4 SE1064009T4 (sv) 2008-09-23

Family

ID=7861630

Family Applications (1)

Application Number Title Priority Date Filing Date
SE99913282T SE1064009T4 (sv) 1998-03-19 1999-03-19 Anvaendning av extract av irisvaexter och Cimicifuga racemosa och tektorigenin saesom oestrogenartat organselektivt laekemedel utan uterotrop verkan

Country Status (21)

Country Link
EP (1) EP1064009B2 (sv)
JP (2) JP2002506827A (sv)
KR (1) KR100623333B1 (sv)
CN (2) CN100444867C (sv)
AT (1) ATE225182T1 (sv)
AU (1) AU755900C (sv)
BR (1) BR9908256A (sv)
CA (1) CA2321444C (sv)
CZ (1) CZ292684B6 (sv)
DE (2) DE19812204A1 (sv)
DK (1) DK1064009T4 (sv)
ES (1) ES2184427T5 (sv)
HK (1) HK1035660A1 (sv)
HU (1) HU227694B1 (sv)
MX (1) MXPA00007986A (sv)
PL (1) PL194096B1 (sv)
PT (1) PT1064009E (sv)
RU (2) RU2228188C2 (sv)
SE (1) SE1064009T4 (sv)
TR (1) TR200002686T2 (sv)
WO (1) WO1999047149A1 (sv)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2000302667A (ja) * 1999-04-23 2000-10-31 Kobe Tennenbutsu Kagaku Kk 豊胸促進剤
JP5106739B2 (ja) * 2000-06-29 2012-12-26 クイック−メッド テクノロジーズ、インク． 化粧品組成物および方法
IL145876A0 (en) 2000-10-17 2002-07-25 Pfizer Prod Inc Methods and kits for improving vascular health
DE10054641A1 (de) * 2000-11-03 2002-05-16 Schaper & Bruemmer Gmbh Verwendung einer Zubereitung von Cimicifuga racemosa
DE10123503A1 (de) * 2001-05-15 2002-11-21 Bionorica Ag Verwendung von Extrakten und Zubereitungen aus Irisgewächsen und Tectorigenin als organselektives Arzneimittel zur Behandlung von sexualhormon-abhängigen Erkrankungen des Urogenitaltraktes
DE10127897B4 (de) * 2001-06-08 2006-04-20 Bionorica Ag Manteltablette mit Pflanzentrockenextrakten
DE10146159A1 (de) * 2001-09-19 2003-04-10 Bionorica Ag Verwendung von Extrakten aus Cimicifuga-Arten als organselektives Arzneimittel zur Behandlung von sexualhormonabhängigen Erkrankungen des Urogenitaltraktes
EP1325681A1 (en) * 2001-12-11 2003-07-09 Société des Produits Nestlé S.A. Composition for promotion of bone growth and maintenance of bone health
DE10206390A1 (de) * 2002-02-15 2003-08-28 Bionorica Ag Verwendung von selektiv den Estrogenrezeptor beta modulierenden phytoestrogenhaltigen Extrakten
JP4605984B2 (ja) * 2002-12-20 2011-01-05 アサヒビール株式会社 ストレス緩和剤
US7902253B2 (en) * 2003-05-15 2011-03-08 Chengdu Dikang Pharmaceutical Institute Isoflavone derivatives of tectorigenin, the preparation thereof and the antiviral medicine containing the same as an effective constituent
EP1591143A1 (en) * 2004-04-26 2005-11-02 Schaper & Brümmer Gmbh & Co. Kg Composition comprising a combination of Calcium, Cimicifugae racemosae rhizoma and vitamin D and its use as a pharmaceutical in conditions or disorders associated with or resulting from calcium deficiency or as a nutritional supplement
EP1588739A1 (en) * 2004-04-23 2005-10-26 Schaper & Brümmer Gmbh & Co. Kg Composition comprising a combination of calcium, Cimicifugae racemosae rhizoma and vitamin D and its use as a pharmaceutical in conditions or disorders associated with or resulting from calcium deficiency or as a nutritional supplement
US7887851B2 (en) 2004-06-07 2011-02-15 Kao Corporation Aromatase activator
CN100381435C (zh) * 2005-03-24 2008-04-16 深圳海王药业有限公司 射干总黄酮提取物及其制备方法和其在药物制备中的应用
EP1745796A1 (de) 2005-07-19 2007-01-24 Bionorica Research GmbH Kombinationspräparat insbesondere zur Therapie des Prostatakarzinoms
CN101057854B (zh) * 2006-05-31 2010-05-12 南京大学 升麻环菠萝蜜烷型三萜类化合物在抗骨质疏松及更年期综合症的用途
DE102007044916A1 (de) 2007-09-19 2009-04-23 Bionorica Ag Kosmetische oder dermatologische Zusammensetzung zur topischen Verwendung
KR100928013B1 (ko) * 2008-01-25 2009-11-24 이화여자대학교 산학협력단 범부채 추출물을 이용한 돌피의 생장 촉진방법 및 이방법을 적용한 중금속 오염 토양의 정화방법
CN101797265A (zh) * 2010-04-09 2010-08-11 中国人民解放军第二军医大学 射干总异黄酮或异黄酮类化合物在制备防治妇女病的药物或食品中的应用
EP2545932A1 (de) 2011-07-12 2013-01-16 Bionorica Se Ausgewählte Cimicifuga-Fraktionen zur Behandlung von Osteoporose
WO2013007807A1 (de) 2011-07-12 2013-01-17 Bionorica Se Ausgewählte cimicifuga-fraktionen zur behandlung von osteoporose
EP2620155A1 (de) 2012-01-30 2013-07-31 Bionorica SE Arzneimittel enthaltend Cimicifuga zur Anwendung bei der Behandlung von Sarkopenie und Herzmuskelschwäche
CN102525907B (zh) * 2012-02-22 2013-06-05 四川省中医药科学院 鸢尾苷元磺酸钠注射液
CN102631363A (zh) * 2012-04-11 2012-08-15 李超生 鸢尾苷在制备防治骨质疏松症的药物中的应用
CN104394874A (zh) * 2012-06-22 2015-03-04 国鼎生物科技股份有限公司 用于治疗动脉硬化性血管病的方法和组合物
AU2013285492B2 (en) 2012-07-03 2015-11-12 Max Zeller Soehne Ag Novel pharmacological use of Cimicifuga extract
JP2014091706A (ja) * 2012-11-02 2014-05-19 Kao Corp Ｇｌｐ−１分泌促進剤
KR101965849B1 (ko) * 2017-03-07 2019-04-04 주식회사 엘지생활건강 텍토리게닌 7-0-자일로실글루코시드를 포함하는 여성 갱년기 증상 완화용 조성물
KR101964841B1 (ko) * 2017-03-07 2019-08-07 주식회사 엘지생활건강 여성 갱년기 증상 개선용 조성물
TWI761372B (zh) * 2017-09-22 2022-04-21 日商東洋新藥股份有限公司 組合物
EP3906040A1 (en) 2018-12-31 2021-11-10 Max Zeller Söhne AG Combination of cimicifuga and petasites extracts for anticancer therapy and prophylaxis

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6330417A (ja) * 1986-07-23 1988-02-09 Tsumura Juntendo Inc 抗アレルギ−剤
DE69601765T2 (de) * 1995-09-07 1999-07-08 Oreal Extrakt von Iridaceen und Zusammensetzungen, die ihn enthalten
CA2235481A1 (en) * 1995-10-23 1997-05-01 Sean M. Kerwin Compositions and methods for treating bone deficit conditions
JPH09301884A (ja) * 1996-05-15 1997-11-25 Ichimaru Pharcos Co Ltd ヒオウギ抽出物及びα−ヒドロキシ酸を含有するテストステロン５α−リダクターゼ阻害剤とその応用
JPH107580A (ja) * 1996-06-15 1998-01-13 Michio Yoshida コラゲナ−ゼ阻害剤
JP3665848B2 (ja) * 1996-09-18 2005-06-29 木村 幸代 ヒメヒオウギズイセン球根抽出液の発酵飲料及びその製造方法
DE19652183C1 (de) * 1996-12-14 1998-02-12 Schaper & Bruemmer Gmbh Verwendung eines Extraktes aus Cimicifuga racemosa

Also Published As

Publication number Publication date
CN100581541C (zh) 2010-01-20
ES2184427T5 (es) 2008-12-16
AU755900C (en) 2005-04-21
WO1999047149A1 (de) 1999-09-23
CZ20002810A3 (cs) 2000-12-13
DE19812204A1 (de) 1999-11-04
HU227694B1 (en) 2011-12-28
CZ292684B6 (cs) 2003-11-12
TR200002686T2 (tr) 2000-12-21
AU755900B2 (en) 2003-01-02
CA2321444A1 (en) 1999-09-23
KR20010040829A (ko) 2001-05-15
EP1064009A1 (de) 2001-01-03
EP1064009B1 (de) 2002-10-02
EP1064009B2 (de) 2008-07-30
SE1064009T4 (sv) 2008-09-23
ATE225182T1 (de) 2002-10-15
PL342486A1 (en) 2001-06-04
RU2003137324A (ru) 2005-06-10
EP1064009B9 (de) 2003-02-05
CA2321444C (en) 2012-10-02
SE1064009T5 (sv) 2003-04-15
DK1064009T4 (da) 2008-08-25
ES2184427T3 (es) 2003-04-01
CN1293575A (zh) 2001-05-02
DK1064009T3 (da) 2002-11-04
HUP0200921A2 (hu) 2002-12-28
RU2263505C2 (ru) 2005-11-10
RU2228188C2 (ru) 2004-05-10
AU3146699A (en) 1999-10-11
CN1509712A (zh) 2004-07-07
HK1035660A1 (en) 2001-12-07
HUP0200921A3 (en) 2004-05-28
CN100444867C (zh) 2008-12-24
PT1064009E (pt) 2003-02-28
BR9908256A (pt) 2000-12-12
MXPA00007986A (es) 2002-08-06
KR100623333B1 (ko) 2006-12-05
JP2002506827A (ja) 2002-03-05
DE59902932D1 (de) 2002-11-07
PL194096B1 (pl) 2007-04-30
JP2010132699A (ja) 2010-06-17

Similar Documents

Publication Publication Date Title
SE1064009T5 (sv) Anvaendning av extract av irisvaexter och Cimicifuga racemosa och tektorigenin saesom oestrogenartat organselektivt laekemedel utan uterotropverkan
Sumbul et al. Role of phenolic compounds in peptic ulcer: An overview
RU2000126476A (ru) Применение экстрактов семейства iridaceae и cimicifuga racemosa и текторигенина в качестве действующего по типу эстрогена орган-селективного лекарственного препарата, не имеющего утеротропного эффекта
WO2002047706A3 (en) Selective cox-2 inhibition from plant extracts
TR200002770T2 (tr) Estrojene bağlı bozuklukların tedavisi
WO2002047708A3 (en) Selective cox-2 inhibition from edible plant extracts
DE60000259D1 (de) Grüntee-extrakte enthaltend catechole und koffein
JP2002506827A5 (sv)
Lopez‐Jornet et al. Effects of potassium apigenin and verbena extract on the wound healing process of SKH‐1 mouse skin
Sowemimo et al. Anti-inflammatory activity of Markhamia tomentosa (Benth.) K. Schum. Ex Engl. ethanolic leaf extract
Costa et al. Hydroalcoholic extract from Baccharis dracunculifolia recovers the gastric ulcerated tissue, and p‐coumaric acid is a pivotal bioactive compound to this action
NO975858L (no) Anvendelse av et ekstrakt av Cimicifuga racemosa
Kakorin et al. Potential biological activity and chemical composition of Caragana Jubata (pall.) Poir.
Durairaj et al. Antiplatelet activity of white and pink Nelumbo nucifera Gaertn flowers
Gu et al. Phytochemical and biological research of Polygoneae medicinal resources
NO975177D0 (no) Farmasöytiske sammensetninger for behandling av alkoholavhengighet
Mostafa et al. Pyrostegia venusta (Ker Gawl.) Miers: a botanical, pharmacological and phytochemical review
DE60030786D1 (de) Murraya koenigii-extrakte zur behandlung von asthma
Ruth et al. Antispermatogenic activity of Aspilia africana methanol leaf extract in male Wistar rats.
DE60113418D1 (de) Anti-karzinogene aktivität von aus der lakritzenwurzel isolierten hydroxylierten chalcon-verbindungen
Kusmardiyani et al. Pyrostegia Genus: An Update Review of Phytochemical Compounds and Pharmacological Activities
Shin et al. Inhibititory Activity of Flavonoid Acetates on the Histamine Release from IgE-Sensitized Mast Cells
Geliebter et al. The Role of Nutrition in Preventing and Treating Breast and Prostate Cancer